Transdermal Drug Delivery Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Transdermal Drug Delivery Systems Market By Application (Cardiovascular, Contraception, Pain Management / Neurological Disorders, Smoking Cessation, Others), By Technology (Electric Current, Electroporation, Radio Frequency, Thermal, Ultrasound, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Transdermal Drug Delivery Systems Market size was valued at USD 53,721.5 million in 2021, growing at a CAGR of 5.1% from 2022 to 2028. Transdermal Drug Delivery Systems Market is the self-contained, discrete dosage applied in the form of patches to the intact skin and delivers medication through the controlled rate. The main aim of transdermal patches is to deliver the medication into the systemic circulation at controlled rates to minimize the intra and interpatient variation. Transdermal drug delivery methods enable systemic drug circulation and maintain clinically efficacious concentrations at a predefined pace with minimum inter-and intrapatient variation by delivering the drug through the skin. It’s a medicated adhesive bandage that sticks to the skin and releases the medicine into the bloodstream. It lessens the strain on the digestive tract and liver that comes with taking pills orally. It increases therapeutic efficacy and safety, keeps drug levels stable in the blood, and solves the drawbacks of traditional oral dosage forms and parenteral formulations. The global market provides a detailed overview and which can be segmented by technology, application, and region. By technology, the transdermal drug delivery systems market has been segmented into electric current, electroporation, radio frequency, thermal, ultrasound, and others. By technology, the electroporation segment is expected to have a significant growth rate over the forecasted period due to the increasing high for electroporation technology in the field of transdermal drug delivery globally. Based on application, the segment has been segregated into cardiovascular, contraception, pain management / neurological disorders, smoking cessation, and others. By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.

 

Transdermal Drug Delivery Systems Market

MARKET SUMMARY
-
5.1%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 5.1%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Transdermal Drug Delivery Systems Market

  • Transdermal Drug Delivery Systems Market is segmented based on application, technology and geography.
  • Furthermore, advancements in the transdermal drug delivery systems and recent product launch expected to bolster the market growth over the forecast period.
  • However, the adaptation rates and compatibility of the many large sized drugs are expected to hamper the market growth during the forecast period.
Market Key Players
  • Boehringer Ingelheim GmbH
  • Generex Biotechnology Corp
  • Actelion Pharmaceuticals Ltd
  • Johnson & Johnson Limited
  • 3M Pharmaceuticals Inc.
  • Mylan Pharmaceuticals Inc.
Transdermal Drug Delivery Systems Market Dynamics

An increase in the global population has significantly increased the demand for geriatric medicines. Also, transdermal drug delivery systems help deliver drugs in a controlled manner, thereby increasing the effectiveness of geriatric medicines. Apart from this, the number of patients suffering from chronic diseases, such as heart disease, diabetes, and arthritis has steadily increased these days, and also these chronic diseases are a leading cause of disability and death globally. Additionally, rising awareness among patients, regarding the use of enormous medicines has also increased. These factors have impacted positively the global transdermal drug delivery systems market growth.


Asia Pacific Got Significant Share

Transdermal Drug Delivery Systems Market

Asia Pacific is expected to emerge as the largest revenue-generating region in the globe transdermal drug delivery market due to the growing patient population suffering from chronic diseases and rising awareness about disease management in both developed and developing countries such as China and India.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Transdermal Drug Delivery Systems Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.

The major factors driving the market growth are the increases in the demand for self-administration of drugs for the long-term treatment of diverse disorders.

Business expansion is a key growth strategy opted by industry players of transdermal drug delivery system.


Report

Table Of Content


Report

Company Profile

  • Novartis AG (Switzerland)
  • Boehringer Ingelheim GmbH (Germany)
  • Generex Biotechnology Corp. (Canada)
  • Echo Therapeutics, Inc. (U.S.)
  • Crescita Therapeutics Inc (Canada)
  • MedPharm (U.K.)
  • Pantec Biosolutions AG (Liechtenstein)
  • Transdermal Corp. (U.S.)
  • Noven Pharmaceuticals, Inc. (U.S.)
  • Actelion Pharmaceuticals Ltd (Switzerland)
  • Johnson & Johnson Limited (U.S.)
  • 3M Pharmaceuticals Inc. (U.S.)
  • Mylan Pharmaceuticals Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)

Description

Transdermal Drug Delivery Systems Market size was valued at USD 53,721.5 million in 2021, growing at a CAGR of 5.1% from 2022 to 2028. Transdermal Drug Delivery Systems Market is the self-contained, discrete dosage applied in the form of patches to the intact skin and delivers medication through the controlled rate. The main aim of transdermal patches is to deliver the medication into the systemic circulation at controlled rates to minimize the intra and interpatient variation. Transdermal drug delivery methods enable systemic drug circulation and maintain clinically efficacious concentrations at a predefined pace with minimum inter-and intrapatient variation by delivering the drug through the skin. It’s a medicated adhesive bandage that sticks to the skin and releases the medicine into the bloodstream. It lessens the strain on the digestive tract and liver that comes with taking pills orally. It increases therapeutic efficacy and safety, keeps drug levels stable in the blood, and solves the drawbacks of traditional oral dosage forms and parenteral formulations. The global market provides a detailed overview and which can be segmented by technology, application, and region. By technology, the transdermal drug delivery systems market has been segmented into electric current, electroporation, radio frequency, thermal, ultrasound, and others. By technology, the electroporation segment is expected to have a significant growth rate over the forecasted period due to the increasing high for electroporation technology in the field of transdermal drug delivery globally. Based on application, the segment has been segregated into cardiovascular, contraception, pain management / neurological disorders, smoking cessation, and others. By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX